- Home
- SOPH vs XBIT Comparison
SOPH vs XBIT Comparison
Compare SOPH & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOPH
- XBIT
- Stock Information
- Founded
- SOPH 2011
- XBIT 2005
- Country
- SOPH Switzerland
- XBIT United States
- Employees
- SOPH N/A
- XBIT N/A
- Industry
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- XBIT Pharmaceuticals and Biotechnology
- Sector
- SOPH Health Care
- XBIT Health Care
- Exchange
- SOPH Nasdaq
- XBIT Nasdaq
- Market Cap
- SOPH 226.6M
- XBIT 211.9M
- IPO Year
- SOPH 2021
- XBIT 2015
- Fundamental
- Price
- SOPH $3.26
- XBIT $6.27
- Analyst Decision
- SOPH Strong Buy
- XBIT
- Analyst Count
- SOPH 3
- XBIT 0
- Target Price
- SOPH $7.00
- XBIT N/A
- AVG Volume (30 Days)
- SOPH 21.3K
- XBIT 64.8K
- Earning Date
- SOPH 11-05-2024
- XBIT 11-13-2024
- Dividend Yield
- SOPH N/A
- XBIT N/A
- EPS Growth
- SOPH N/A
- XBIT N/A
- EPS
- SOPH N/A
- XBIT N/A
- Revenue
- SOPH $64,488,000.00
- XBIT N/A
- Revenue This Year
- SOPH $7.20
- XBIT N/A
- Revenue Next Year
- SOPH $15.71
- XBIT N/A
- P/E Ratio
- SOPH N/A
- XBIT N/A
- Revenue Growth
- SOPH 9.85
- XBIT N/A
- 52 Week Low
- SOPH $2.70
- XBIT $3.83
- 52 Week High
- SOPH $7.37
- XBIT $9.96
- Technical
- Relative Strength Index (RSI)
- SOPH 46.64
- XBIT 42.25
- Support Level
- SOPH $3.06
- XBIT $6.06
- Resistance Level
- SOPH $3.47
- XBIT $7.24
- Average True Range (ATR)
- SOPH 0.18
- XBIT 0.51
- MACD
- SOPH -0.00
- XBIT -0.03
- Stochastic Oscillator
- SOPH 45.45
- XBIT 17.72
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.